First professional · San Francisco, California

Is Pharmacy, Pharmaceutical Sciences, and Administration at University of California-San Francisco worth it?

High confidence High confidence: 100+ graduates behind the earnings figures.

The verdict · all families, in-state, half paid with loans

Pays back fast: graduates typically recover the cost in about 2.4 years.

Earnings 1 year after graduating: $87,764; Treasury AY2020-21, AY2021-22 pooled earnings cohort measured in CY2022, CY2023, inflation adjusted to 2024 dollars
Earnings 4 years after graduating: $192,829; Treasury AY2017-2018, AY2018-2019 pooled earnings cohort measured in CY2022, CY2023, inflation adjusted to 2024 dollars
Typical federal debt at graduation: $108,719; NSLDS pooled AY2022-23, AY2023-24 cohort
Typical borrowing (no graduate net price is published): $115k (likely $115k – $115k); AcadYr 2024-25, reported in IPEDS DCY2025-26
Earnings bump, year 4: $124k a year vs bachelor's graduates 4 years out in CA; 2023 ACS 5-year pooled, adjusted to 2024 dollars
Payback: 2.4 years (likely 2.1–2.8); Bump vs net cost plus loan interest
10-year net return: $697k (likely $563k – $819k); Today's dollars
20-year net return: $2.18M (likely $1.82M – $2.52M); Today's dollars

Scorecard reports no net price for graduate programs; cost is based on what graduates typically borrowed.